LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNE RESPONSES AGAINST HBsAg IN IMMUNODEFICIENT NON-RESPONDERS TO HEPATITIS B VACCINATION
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8628), 15-18
- https://doi.org/10.1016/s0140-6736(89)91674-7
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor.The Journal of Experimental Medicine, 1987
- Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.JCI Insight, 1987
- DINITROCHLOROBENZENE SKIN TESTING PREDICTS RESPONSE TO HEPATITIS B VACCINE IN DIALYSIS PATIENTSThe Lancet, 1985
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Active hepatitis B vaccination of dialysis patients and medical staffKidney International, 1984
- Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptorNature, 1983
- Hepatitis B Vaccine in Medical Staff of Hemodialysis UnitsNew England Journal of Medicine, 1982
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFFThe Lancet, 1981
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978